Vivifi Medical has developed the Calexis-Lap device, a suture-less laparoscopic tool that enables the rapid connection of blood vessels for the treatment of varicocele and benign prostatic hyperplasia (BPH). This technology addresses the complications and recurrence rates associated with traditional surgical methods, offering a minimally invasive outpatient procedure with quick recovery times.
Funding
Funding not disclosed
Founders
Product
Problem
Current surgical methods for treating varicocele and benign prostatic hyperplasia (BPH) can result in complications and high recurrence rates. Traditional procedures often require sutures, leading to longer recovery times and increased risk of post-operative issues.
Solution
Vivifi Medical offers the Calexis-Lap device, a suture-less laparoscopic tool designed for rapid blood vessel connection in varicocele and BPH treatments. This minimally invasive technology aims to reverse chronic conditions caused by venous insufficiency by addressing the hormonal root cause of BPH. The Calexis-Lap procedure is performed on an outpatient basis, facilitating quick recovery times and minimizing patient discomfort. By treating the underlying cause, the device ensures very low recurrence rates and eliminates the risk of sexual or urinary complications, potentially boosting testosterone levels and overall sexual health. The technology changes the way laparoscopic and robotic surgery is performed for vascular procedures.
Target Audience
The primary customers are surgeons specializing in urology and vascular procedures, as well as hospitals and clinics focused on minimally invasive treatments for BPH and varicocele.
Features
- Suture-less design for rapid and secure blood vessel connection
- Minimally invasive laparoscopic approach
- Designed to redirect testosterone-rich blood away from the prostate
- Outpatient procedure for patient convenience
- Reduced risk of sexual or urinary complications